We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.3B
AUM Growth
+$50.2M
Cap. Flow
-$180M
Cap. Flow %
-4.19%
Top 10 Hldgs %
8.21%
Holding
2,738
New
923
Increased
478
Reduced
355
Closed
498

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$20.1M
2
AXAC
AXIOS Sustainable Growth Acquisition Corporation
AXAC
+$11M
3
CNGL
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
+$9.93M
4
SAGA
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
+$9.76M
5
NUBIU
Nubia Brand International Corp. Unit
NUBIU
+$9.67M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$103M
2
PFE icon
Pfizer
PFE
+$63M
3
CRM icon
Salesforce
CRM
+$40.7M
4
XLNX
Xilinx Inc
XLNX
+$32.9M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$26M

Sector Composition

Rank Sector Weight
1 Financials 13.47%
2 Healthcare 7.77%
3 Technology 7.7%
4 Consumer Discretionary 4.85%
5 Energy 4.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MITO
2176
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$34K ﹤0.01%
48,397
– –
SPIR.WS
2177
DELISTED
Spire Global, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per whole share
SPIR.WS
$32K ﹤0.01%
15,094
-25,009
-62% -$7.69K
GYRE icon
2178
Gyre Therapeutics
GYRE
$714M
$30K ﹤0.01%
6,122
– –
ONCT
2179
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$28K ﹤0.01%
995
– –
QNGY.WS
2180
DELISTED
Quanergy Systems, Inc. Warrants, each whole warrant exercisable for one twentieth (1/20) share of Common Stock at an exercise price of $230.00 per full share
QNGY.WS
$26K ﹤0.01%
+13,950
New +$4.4K
GNCA
2181
DELISTED
Genocea Biosciences, Inc.
GNCA
$25K ﹤0.01%
19,916
– –
HHGCR
2182
DELISTED
HHG Capital Corporation Rights
HHGCR
$25K ﹤0.01%
125,000
– –
UPH.WS
2183
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$21K ﹤0.01%
17,813
-433
-2% -$133
SEEL
2184
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$20K ﹤0.01%
6
– –
DRUG
2185
Bright Minds Biosciences
DRUG
$793M
$17K ﹤0.01%
2,208
– –
FSRD
2186
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
$17K ﹤0.01%
+11,325
New +$58K
DRMAW icon
2187
Dermata Therapeutics Warrant
DRMAW
$14.1K
$15K ﹤0.01%
12,000
– –
ENVB icon
2188
Enveric Biosciences
ENVB
$6.28M
$15K ﹤0.01%
5
– –
APTO
2189
DELISTED
Aptose Biosciences, Inc.
APTO
$14K ﹤0.01%
23
– –
BRLIR
2190
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$13K ﹤0.01%
74,155
– –
DFTX
2191
Definium Therapeutics
DFTX
$6.12B
$12K ﹤0.01%
736
– –
ORTX
2192
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$11K ﹤0.01%
1,493
– –
CREXW
2193
DELISTED
Creative Realities, Inc. Warrant
CREXW
$9K ﹤0.01%
10,906
– –
GUT.RT
2194
DELISTED
The Gabelli Utility Trust Rights (expiring April 19, 2022)
GUT.RT
$7K ﹤0.01%
+37,500
New +$6.71K
BREZR
2195
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
$4K ﹤0.01%
28,211
– –
KYCHR
2196
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$3K ﹤0.01%
+20,000
New +$3.6K
BWAQR
2197
DELISTED
Blue World Acquisition Corporation Right
BWAQR
$2K ﹤0.01%
+15,000
New +$2.22K
AAL icon
2198
PUT
American Airlines Group
AAL
$10.6B
– –
-77,000
Closed -$1.38M
AAP icon
2199
Advance Auto Parts
AAP
$3.49B
– –
-1,298
Closed -$311K
ACET icon
2200
CALL
Adicet Bio
ACET
$74.2M
– –
-1,419
Closed -$397K
86 87
88
89 90

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q1 2022 Portfolio in Review

As of Q1 2022, Boothbay Fund Management held 2,738 positions worth $4.3B, up 1.2% from $4.25B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Boothbay Fund Management withdrew a net $180M in Q1 2022, closing 498 positions and reducing 355 holdings. Its most notable exit was Xilinx Inc, an estimated $32.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in AXIOS Sustainable Growth Acquisition Corporation worth $11M.

  • Boothbay Fund Management's largest Q1 2022 buy was AXIOS Sustainable Growth Acquisition Corporation: 1,100,000 shares worth $11M.
  • Boothbay Fund Management added most to iShares MBS ETF in Q1 2022, an estimated $20.1M increase.
  • Boothbay Fund Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $103M.
  • Boothbay Fund Management fully exited Xilinx Inc in Q1 2022, selling an estimated $32.9M.
  • Boothbay Fund Management's ten largest holdings make up 8.2% of its $4.3B portfolio in Q1 2022.
  • Boothbay Fund Management opened 923 new positions and closed 498 in Q1 2022.
  • Boothbay Fund Management's portfolio value rose 1.2% quarter-over-quarter to $4.3B.

Based on Boothbay Fund Management's 13F filing for Q1 2022, filed 16 May 2022.